agilon health (NYSE:AGL) Shares Gap Down – Here’s Why

agilon health, inc. (NYSE:AGL)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $3.63, but opened at $3.24. agilon health shares last traded at $3.99, with a volume of 2,629,744 shares.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Barclays decreased their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Stifel Nicolaus upped their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Wednesday. Finally, Sanford C. Bernstein lifted their target price on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $4.10.

agilon health Stock Performance

The stock has a market cap of $1.50 billion, a P/E ratio of -3.88 and a beta of 0.66. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $2.89 and a two-hundred day moving average price of $3.04.

Insider Transactions at agilon health

In other news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John William Wulf bought 45,000 shares of the stock in a transaction dated Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 77,500 shares of company stock valued at $169,600. 3.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of agilon health by 24.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock valued at $1,516,000 after acquiring an additional 157,610 shares during the period. Two Sigma Advisers LP grew its stake in agilon health by 4,393.5% during the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock worth $914,000 after buying an additional 470,100 shares during the last quarter. Two Sigma Investments LP raised its stake in agilon health by 73.7% in the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock valued at $1,630,000 after buying an additional 363,855 shares during the last quarter. State of Wyoming grew its stake in shares of agilon health by 89.3% during the fourth quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after acquiring an additional 57,802 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in agilon health during the 4th quarter worth about $768,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.